companies / continuitybiosciences-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,995,5813.0M | ○ |
|---|---|---|
| founded | null | |
| hq | Bradenton, Florida | |
| industry | unknown | |
| stage | null |
Continuity Biosciences develops precision-delivery platforms that route small molecules, biologics, and cell therapies to specific tissues to widen the therapeutic window. Pipeline indications include type 1 diabetes, pancreatic cancer, HIV, oral and breast cancer, and medical aesthetics. The company positions itself between medtech and biotech, pairing engineered devices with biological payloads.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 2,995,5813.0M | null | ○ |
Cloudflare, Google Font API, Google Hosted Libraries, Google Tag Manager, Webflow, jquery 3.5.1
| fact | status | src |
|---|---|---|
| Grant, $3.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |